Psychometric Properties of Rapid Word-Based Rate Measures in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Comparisons With Syllable-Based Rate Tasks.


Journal

Journal of speech, language, and hearing research : JSLHR
ISSN: 1558-9102
Titre abrégé: J Speech Lang Hear Res
Pays: United States
ID NLM: 9705610

Informations de publication

Date de publication:
08 11 2021
Historique:
pubmed: 27 10 2021
medline: 15 12 2021
entrez: 26 10 2021
Statut: ppublish

Résumé

Purpose Rapid maximum performance repetition tasks have increasingly demonstrated their utility as clinimetric markers supporting diagnosis and monitoring of bulbar disease in amyotrophic lateral sclerosis (ALS). A recently developed protocol uses novel real-word repetitions instead of traditional nonword/syllable sequences in hopes of improving sensitivity to motor speech impairments by adding a phonological target constraint that would activate a greater expanse of the motor speech neuroanatomy. This study established the psychometric properties of this novel clinimetric protocol in its assessment of bulbar ALS and compared performance to traditional syllable sequence dysdiadochokinetic (DDK) tasks. Specific objectives were to (a) compare rates between controls and speakers with symptomatic versus presymptomatic bulbar disease, (b) characterize their discriminatory ability in detecting presymptomatic bulbar disease compared to healthy speech, (c) determine their articulatory movement underpinnings, and (d) establish within-individual longitudinal changes. Method DDK and novel tongue ("ticker"-TAR) and labial ("pepper"-LAR) articulatory rates were compared between

Identifiants

pubmed: 34699273
doi: 10.1044/2021_JSLHR-21-00038
pmc: PMC9499363
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4178-4191

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC009890
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC017291
Pays : United States

Références

J Commun Disord. 2010 Jan-Feb;43(1):6-20
pubmed: 19683250
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):329-36
pubmed: 11464851
Neurol Clin. 1987 May;5(2):231-50, v-vi
pubmed: 11681401
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
PLoS One. 2016 May 05;11(5):e0154971
pubmed: 27148967
Clin Linguist Phon. 2014 Nov;28(11):799-811
pubmed: 24724615
Muscle Nerve. 1989 Oct;12(10):833-41
pubmed: 2608080
Amyotroph Lateral Scler. 2010;11(1-2):4-15
pubmed: 20184513
J Speech Lang Hear Res. 2011 Oct;54(5):1295-301
pubmed: 21498575
Brain Lang. 2002 Mar;80(3):556-75
pubmed: 11896657
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb;21(1-2):34-41
pubmed: 31694409
Lang Speech. 2010;53(Pt 1):49-69
pubmed: 20415002
AMA Arch Neurol Psychiatry. 1953 Feb;69(2):171-92
pubmed: 13007227
Int J Lang Commun Disord. 2017 May;52(3):301-310
pubmed: 27432555
Front Neurol. 2019 Feb 19;10:106
pubmed: 30837936
Folia Phoniatr (Basel). 1993;45(2):84-9
pubmed: 8325574
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174
pubmed: 28054827
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):494-500
pubmed: 23898888
Dysphagia. 2018 Dec;33(6):840-847
pubmed: 29774424
Folia Phoniatr Logop. 2000 Jul-Aug;52(4):187-96
pubmed: 10782011
J Speech Hear Res. 1993 Dec;36(6):1158-67
pubmed: 8114482
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):385-395
pubmed: 31088163
Arch Oral Biol. 2010 Apr;55(4):325-31
pubmed: 20236625
Brain. 1995 Jun;118 ( Pt 3):707-19
pubmed: 7600088
J Speech Lang Hear Res. 2008 Jun;51(3):596-611
pubmed: 18506038
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol Sci. 2001 Oct 15;191(1-2):43-53
pubmed: 11676991
Folia Phoniatr (Basel). 1982;34(2):106-12
pubmed: 7129273
J Speech Hear Res. 1980 Dec;23(4):894-908
pubmed: 7442219
J Neurol Sci. 1993 Aug;118(1):48-55
pubmed: 8229050
Clin Linguist Phon. 2011 Jan;25(1):66-79
pubmed: 20932172
Neurology. 2006 Nov 14;67(9):1652-8
pubmed: 17101899
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):358-366
pubmed: 28355886
J Speech Lang Hear Res. 2016 Oct 1;59(5):887-899
pubmed: 27679842
Brain Inj. 2006 May;20(5):529-45
pubmed: 16716999
J Speech Hear Res. 1994 Feb;37(1):28-37
pubmed: 8170127
J Med Speech Lang Pathol. 2013 Mar;21(1):1-13
pubmed: 27453680
Am J Speech Lang Pathol. 2021 Jan 27;30(1):137-149
pubmed: 33290086
Int J Lang Commun Disord. 1998;33 Suppl:481-6
pubmed: 10343741
J Speech Lang Hear Res. 2007 Apr;50(2):352-60
pubmed: 17463234
J Speech Hear Res. 1988 Dec;31(4):670-80
pubmed: 3230897
J Neuropathol Exp Neurol. 2020 Mar 1;79(3):284-295
pubmed: 31951003
J Neurol Sci. 1994 Jul;124 Suppl:64-6
pubmed: 7807146
J Speech Lang Hear Res. 2019 Jan 22;63(1):59-73
pubmed: 31940257
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):351-357
pubmed: 28425762
Int J Speech Lang Pathol. 2018 Nov;20(6):610-623
pubmed: 30253671
Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3 Suppl 1:S13-8
pubmed: 12396795
Int J Speech Lang Pathol. 2019 Dec;21(6):564-571
pubmed: 30696280
PLoS One. 2016 Jan 20;11(1):e0147573
pubmed: 26789001
J Speech Lang Hear Res. 2018 Nov 8;61(11):2757-2771
pubmed: 30383220
J Commun Disord. 2012 Jan-Feb;45(1):35-45
pubmed: 22000045
J Commun Disord. 2016 May-Jun;61:97-105
pubmed: 27110704

Auteurs

Sanjana Shellikeri (S)

Penn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia.
Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.

Reeman Marzouqah (R)

Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.

Benjamin Rix Brooks (BR)

Department of Neurology, Carolinas Medical Center, Carolinas Neuromuscular/ALS-MDA Care Center Atrium Health Neurosciences Institute, University of North Carolina, Charlotte.

Lorne Zinman (L)

Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
LC Campbell Cognitive Neurology Research Group, Sunnybrook Research Institute, University of Toronto, Ontario, Canada.

Jordan R Green (JR)

Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.

Yana Yunusova (Y)

Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Toronto Rehabilitation Institute (KITE), University Health Network, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH